The company also expects its annual set deployment to be approximately $25.0M and expects to generate $3M-$4M of adjusted EBITDA forFY23.
Protect Your Portfolio Against Market Uncertainty
- Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
- Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on KIDS:
- OrthoPediatrics Corp. Reports Fourth Quarter and Full Year 2022 Financial Results
- OrthoPediatrics Corp. to Report Fourth Quarter and Full Year 2022 Financial Results on March 1, 2023
- OrthoPediatrics publishes ESG summary report
- OrthoPediatrics Corp. Publishes Environmental, Social, and Governance (“ESG”) Summary Report
- OrthoPediatrics price target raised to $56 from $47 at Truist